NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US
April 05, 2024 13:35 ET
|
NEUROVIGIL, INC.
NeuroVigil Closed $6 B Series B Deal.
Ascend Broker to Launch at Medicarians 2024
April 05, 2024 12:00 ET
|
Bloom Insurance LLC
Bloomington, IN, April 05, 2024 (GLOBE NEWSWIRE) -- Bloom, an insurance services and technology provider, will launch its new multi-carrier quote-and-enroll technology tool, Ascend Broker, at...
The American Journal of Managed Care® (AJMC®)’s Institute for Value-Based Medicine® (IVBM®) hosts event to highlight treatment options for obesity and minimizing risk of type 2 diabetes and cardiovascular disease
April 05, 2024 12:00 ET
|
The American Journal of Managed Care
CRANBURY, N.J., April 05, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, is pleased to...
Activation of PA Licensure Compact to Improve Access to Patient Care
April 05, 2024 11:23 ET
|
American Academy of Physicians Associates
ALEXANDRIA, Va., April 05, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA), Federation of State Medical Boards (FSMB), and National Commission on Certification of...
HiberCell Announces Recent Publication and Poster Presentations for its Novel GCN2 Activator, HC-7366
April 05, 2024 10:00 ET
|
HiberCell, Inc.
HiberCell Announces Recent Publication and Poster Presentations for its Novel GCN2 Activator, HC-7366
Unlocking Flavor: The Rise of Taste Modulators Market in the Global Industry
April 05, 2024 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 05, 2024 (GLOBE NEWSWIRE) -- Taste modulators, also known as flavor modulators, are substances or compounds that can alter or modify the perception of taste. These substances can...
US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
April 05, 2024 09:17 ET
|
Spherix Global Insights
EXTON, PA, April 05, 2024 (GLOBE NEWSWIRE) -- As the first treatment to gain FDA approval for metabolic dysfunction-associated steatohepatitis (MASH), Madrigal Pharmaceuticals’ Rezdiffra...
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024 08:58 ET
|
PharmAla Biotech
PharmAla Biotech announces that its Australian Joint Venture, Cortexa, has initiated manufacturing of LaNeo MDMA in Australia.
Medical Robots Market is Expected to Reach $33.8 billion | MarketsandMarkets™
April 05, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 05, 2024 (GLOBE NEWSWIRE) -- Medical Robots market in terms of revenue was estimated to be worth $16.0 billion in 2023 and is poised to reach $33.8 billion by 2029, growing at a CAGR...
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
April 05, 2024 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial...